Note payable to DIRECTV
Vertex Pharmaceuticals Note payable to DIRECTV decreased by 3.0% to $428.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.0%, from $363.00M to $428.30M. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows an upward trend with a 6.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase indicates higher short-term debt obligations to related parties, while a decrease reflects repayment or settlement of these specific liabilities. High levels may suggest reliance on related-party financing for working capital needs.
Detailed definition
This represents a short-term financial obligation owed to a related party, specifically categorized as a current liabili...
Peer comparison
Comparable to other 'Notes Payable to Related Parties' or 'Due to Affiliates' found in the current liabilities section of peer company balance sheets.
note_payable_directvHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $226.36M | $201.41M | $268.40M | $286.10M | $238.70M | $218.00M | $311.50M | $377.00M | $391.00M | $316.20M | $527.20M | $648.60M | $279.30M | $357.60M | $363.00M | $386.40M | $425.40M | $441.50M | $428.30M |
| QoQ Change | — | -11.0% | +33.3% | +6.6% | -16.6% | -8.7% | +42.9% | +21.0% | +3.7% | -19.1% | +66.7% | +23.0% | -56.9% | +28.0% | +1.5% | +6.4% | +10.1% | +3.8% | -3.0% |
| YoY Change | — | — | — | — | +5.5% | +8.2% | +16.1% | +31.8% | +63.8% | +45.0% | +69.2% | +72.0% | -28.6% | +13.1% | -31.1% | -40.4% | +52.3% | +23.5% | +18.0% |
Note payable to DIRECTV at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's note payable to directv?
- Vertex Pharmaceuticals (VRTX) reported note payable to directv of $428.30M in Q4 2025.
- How has Vertex Pharmaceuticals's note payable to directv changed year-over-year?
- Vertex Pharmaceuticals's note payable to directv increased by 18.0% year-over-year, from $363.00M to $428.30M.
- What is the long-term trend for Vertex Pharmaceuticals's note payable to directv?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's note payable to directv has grown at a 6.2% compound annual growth rate (CAGR), from $317.42M to $428.30M.
- What does note payable to directv mean?
- A short-term debt obligation owed to a related business entity.